![]() | Up a level |
Pett, Sarah L, Spyer, Moira, Haddow, Lewis J, Nhema, Ruth, Benjamin, Laura A ORCID: 0000-0002-9685-1664, Najjuka, Grace, Bilima, Sithembile, Daud, Ibrahim, Musoro, Godfrey, Kitabalwa, Juliet et al (show 11 more authors)
(2021)
Benefits of enhanced infection prophylaxis at antiretroviral therapy initiation by cryptococcal antigen status.
AIDS, 35 (4).
pp. 585-594.
Paton, Nicholas I, Kityo, Cissy, Thompson, Jennifer, Nankya, Immaculate, Bagenda, Leonard, Hoppe, Anne, Hakim, James, Kambugu, Andrew, van Oosterhout, Joep J, Kiconco, Mary et al (show 5 more authors)
(2017)
Nucleoside reverse-transcriptase inhibitor cross-resistance and outcomes from second-line antiretroviral therapy in the public health approach: an observational analysis within the randomised, open-label, EARNEST trial.
The lancet. HIV, 4 (8).
e341-e348.
Nkhata, Misheck J, Muzambi, Margaret, Ford, Deborah, Chan, Adrienne K, Abongomera, George, Namata, Harriet, Mambule, Ivan, South, Annabelle, Revill, Paul, Grundy, Caroline et al (show 11 more authors)
(2016)
Shifting human resources for health in the context of ART provision: qualitative and quantitative findings from the Lablite baseline study.
BMC HEALTH SERVICES RESEARCH, 16 (1).
660-.